Subcutaneous administration is likely to be an important factor in generating an immunogenic response.
Fred Bader, Ph.D.
Advertisement
Articles by Fred Bader, Ph.D.
Advertisement
Latest Updated Articles
Immunogenicity of Biopharmaceuticals: An Example from ErythropoietinPublished: August 1st 2005 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Report - Digital Transformation in Biopharma: The Gap Between Hype and Implementation
2
Reducing CAR-T Manufacturing Times and Cost: Q&A with Trenchant’s Jon Ellis
3
How Big Biopharma Investment in CGTs Will Redefine the Industry Pipeline
4
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
5
